Drug Trial Radar · NCT02586623
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Last checked: Nov 20, 2026Latest source record: Aug 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
453
Actual
Start
Feb 11, 2016
Primary completion
Jul 21, 2022
Study completion Sep 9, 2022
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Oct 26, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the time to treatment intervention in patients with Parkinson's Disease (PD), Multiple System Atrophy (MSA), Pure Autonomic Failure (PAF), Non-Diabetic Autonomic Neuropathy (NDAN) or Dopamine Beta Hydroxylase (DBH) Deficiency who have been previously stabilized with droxidopa therapy for symptoms of neurogenic orthostatic hypotension (NOH) (dizziness, light-headedness, or feelings that they are about to black out)
Conditions
- Symptomatic Neurogenic Orthostatic Hypotension
Interventions
Droxidopa capsulesDrug
100, 200 or 300 mg
Placebo capsulesDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time To InterventionTime frame: Randomization (Day 0) up to Week 12
Locations
168 sites in 1 country. Site status is shown where the registry gives one.
MDFirst Research - Chandler
Chandler, Arizona
21st Century Neurology
Phoenix, Arizona
Movement Disorders Center of Arizona
Scottsdale, Arizona
Center For Neurosciences
Tucson, Arizona
Movement Disorder Clinic - The University of Arizona
Tucson, Arizona
University of Arizona Health Sciences Center, Department Of Neurology
Tucson, Arizona
Arkansas Cardiology Clinic
Little Rock, Arkansas
East Bay Physicians Medical Group
Berkeley, California
Sutter East Bay Medical Foundation
Berkeley, California
The Parkinson's and Movement Disorder Institute
Fountain Valley, California
Behavioral Research Specialists, LLC
Glendale, California
Loma Linda University Medical Center
Loma Linda, California
University Of Southern California
Los Angeles, California
Parkinson's Institute and Clinical Center
Mountain View, California
Diverse Research Solutions, LLC
Oxnard, California
Focilmed
Oxnard, California
Parkinsons Disease & Movement Disorder of Silicon Valley
Palo Alto, California
Neurosearch, Inc. - Pasedena
Pasadena, California
Neurosearch, Inc. - Ventura
Pasadena, California
SC3 Research Group
Pasadena, California
Neurosearch, Inc. - Reseda
Reseda, California
Radiological Associates of Sacramento
Sacramento, California
Sutter Neuroscience
Sacramento, California
The Parkinson's Institute and Clinical Center
Sunnyvale, California
Neurosearch Inc. - Torrance
Torrance, California
Colorado Springs Neurological Associates
Colorado Springs, Colorado
Associated Neurologists, P.C.
Danbury, Connecticut
Associated Neurologists of Southern Connecticut, P.C.
Fairfield, Connecticut
Eastern Connecticut Neurology Specialists, LLC
Manchester, Connecticut
Yale-New Haven Hospital
New Haven, Connecticut
Yale Neurology / Hypertension Program
New Haven, Connecticut
Yale University School Of Medicine
New Haven, Connecticut
Christiana Care Neurology Specialists
Newark, Delaware
Georgetown University
Washington D.C., District of Columbia
MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)
Washington D.C., District of Columbia
Neurology Offices Of South Florida
Boca Raton, Florida
Parkinson's Disease And Movement Disorders Center of Boca Raton
Boca Raton, Florida
South Florida Neurology Associates, P.A.
Boca Raton, Florida
Innovative Research of West Florida
Clearwater, Florida
UF Center for Movement Disorders and Neurorestoration
Gainesville, Florida
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.